Elevation Oncology discontinues EO-3021 for gastric and gastroesophageal junction cancers after phase 1 trial shows ...

I prayed to God and I said, ‘You know, if you just let me live, I’ll do anything I can to make sure that other people have this information,'” New Jersey mom Elaine ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.

The study found that gastric cells in some individuals carried three copies of certain chromosomes, hinting toward exposure ...

Early colon cancer symptoms, like bloating and abdominal pain, can mimic symptoms of celiac disease, IBS, and gluten ...

The FDA has approved Keytruda plus chemotherapy in HER2+ gastric or GEJ adenocarcinoma with PD-L1–positive expression, based on KEYNOTE-811 data.

In recently published work from Air Force Medical University, analysis of tumor tissues isolated from different patient-derived xenografts revealed significantly increased expression of FXYD5 in the ...

"Our results demonstrate that, despite complete resection and perioperative chemotherapy, patients with [locally advanced gastric cancer] still face a considerable risk for tumor relapse," Huang ...

Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...